Medical Properties Trust Stock EBITDA

MPW Stock

USD 4.52 0.10 2.26%

Medical Properties Trust fundamentals help investors to digest information that contributes to Medical Properties' financial success or failures. It also enables traders to predict the movement of Medical Stock. The fundamental analysis module provides a way to measure Medical Properties' intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Medical Properties stock.

		Last Reported	Projected for Next Year
	EBITDA	684.6 M	486.5 M

EBITDA is likely to drop to about 486.5 M in 2024.

This module does not cover all equities due to inconsistencies in global equity categorizations. Continue to Equity Screeners to view more equity screening tools.

Medical Properties Trust Company EBITDA Analysis

Medical Properties' EBITDA stands for earnings before interest, taxes, depreciation, and amortization. It is a measure of a company operating cash flow based on data from the company income statement and is a very good way to compare companies within industries or across different sectors. However, unlike Operating Cash Flow, EBITDA does not include the effects of changes in working capital.

EBITDA

Revenue

-

Basic Expenses

More About EBITDA | All Equity Analysis

Current Medical Properties EBITDA

684.64 M

Most of Medical Properties' fundamental indicators, such as EBITDA, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Medical Properties Trust is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.

Medical EBITDA Driver Correlations

Understanding the fundamental principles of building solid financial models for Medical Properties is extremely important. It helps to project a fair market value of Medical Stock properly, considering its historical fundamentals such as EBITDA. Since Medical Properties' main accounts across its financial reports are all linked and dependent on each other, it is essential to analyze all possible correlations between related accounts. However, instead of reviewing all of Medical Properties' historical financial statements, investors can examine the correlated drivers to determine its overall health. This can be effectively done using a conventional correlation matrix of Medical Properties' interrelated accounts and indicators.

	Total Assets	Accounts Payable	Total Liab	Common Stock	Total Stockholder Equity	Net Debt	Retained Earnings	Long Term Debt	Net Receivables	Total Current Assets	Current Deferred Revenue	Good Will	Short Term Debt	Intangible Assets	Treasury Stock	Net Tangible Assets	Long Term Debt Total	Capital Surpluse	Deferred Long Term Liab	Long Term Investments	Property Plant Equipment	Short Long Term Debt	Cash And Equivalents	Net Invested Capital	Net Working Capital	Capital Stock
Total Assets		0.65	1.0	0.98	0.99	0.99	-0.15	0.99	0.82	0.87	0.37	0.46	0.39	0.01	-0.85	0.94	0.98	0.94	-0.58	0.7	0.91	0.8	0.43	0.94	0.54	0.94
Accounts Payable	0.65		0.65	0.59	0.66	0.66	0.02	0.62	0.61	0.6	-0.01	0.62	0.0	0.3	-0.48	0.63	0.67	0.61	-0.58	0.2	0.69	0.58	0.2	0.79	0.35	0.79
Total Liab	1.0	0.65		0.97	0.98	0.99	-0.19	0.99	0.82	0.85	0.36	0.45	0.44	0.02	-0.82	0.93	0.99	0.93	-0.54	0.68	0.92	0.83	0.37	0.94	0.49	0.95
Common Stock	0.98	0.59	0.97		0.99	0.96	-0.19	0.97	0.75	0.85	0.46	0.38	0.3	-0.1	-0.86	0.92	0.96	0.93	-0.59	0.76	0.88	0.77	0.47	0.87	0.52	0.89
Total Stockholder Equity	0.99	0.66	0.98	0.99		0.96	-0.08	0.98	0.81	0.89	0.36	0.49	0.32	0.01	-0.87	0.95	0.96	0.95	-0.62	0.71	0.88	0.75	0.5	0.92	0.59	0.93
Net Debt	0.99	0.66	0.99	0.96	0.96		-0.22	0.99	0.8	0.8	0.35	0.43	0.47	0.04	-0.79	0.91	0.99	0.91	-0.49	0.68	0.94	0.85	0.28	0.95	0.43	0.95
Retained Earnings	-0.15	0.02	-0.19	-0.19	-0.08	-0.22		-0.09	0.24	0.18	-0.22	0.29	-0.11	0.22	-0.11	-0.01	-0.29	-0.06	-0.23	-0.27	-0.41	-0.51	0.42	-0.09	0.65	-0.17
Long Term Debt	0.99	0.62	0.99	0.97	0.98	0.99	-0.09		0.86	0.88	0.36	0.45	0.47	0.03	-0.84	0.94	0.97	0.93	-0.55	0.66	0.88	0.78	0.41	0.94	0.57	0.93
Net Receivables	0.82	0.61	0.82	0.75	0.81	0.8	0.24	0.86		0.9	0.23	0.45	0.49	0.12	-0.7	0.85	0.75	0.82	-0.58	0.32	0.58	0.56	0.43	0.87	0.76	0.8
Total Current Assets	0.87	0.6	0.85	0.85	0.89	0.8	0.18	0.88	0.9		0.26	0.56	0.27	0.07	-0.82	0.9	0.81	0.86	-0.69	0.46	0.65	0.55	0.73	0.85	0.84	0.84
Current Deferred Revenue	0.37	-0.01	0.36	0.46	0.36	0.35	-0.22	0.36	0.23	0.26		-0.57	-0.01	-0.92	-0.28	0.31	0.32	0.32	-0.26	0.4	0.24	0.21	0.17	0.21	0.17	0.22
Good Will	0.46	0.62	0.45	0.38	0.49	0.43	0.29	0.45	0.45	0.56	-0.57		0.1	0.79	-0.51	0.5	0.47	0.47	-0.4	0.16	0.46	0.31	0.44	0.54	0.48	0.55
Short Term Debt	0.39	0.0	0.44	0.3	0.32	0.47	-0.11	0.47	0.49	0.27	-0.01	0.1		0.2	-0.21	0.35	0.4	0.33	0.22	0.17	0.37	0.56	-0.23	0.42	0.1	0.35
Intangible Assets	0.01	0.3	0.02	-0.1	0.01	0.04	0.22	0.03	0.12	0.07	-0.92	0.79	0.2		-0.04	0.06	0.06	0.05	0.04	-0.18	0.1	0.09	-0.05	0.17	0.05	0.16
Treasury Stock	-0.85	-0.48	-0.82	-0.86	-0.87	-0.79	-0.11	-0.84	-0.7	-0.82	-0.28	-0.51	-0.21	-0.04		-0.85	-0.79	-0.84	0.66	-0.71	-0.67	-0.59	-0.63	-0.7	-0.67	-0.71
Net Tangible Assets	0.94	0.63	0.93	0.92	0.95	0.91	-0.01	0.94	0.85	0.9	0.31	0.5	0.35	0.06	-0.85		0.9	0.99	-0.61	0.72	0.8	0.72	0.52	0.9	0.64	0.89
Long Term Debt Total	0.98	0.67	0.99	0.96	0.96	0.99	-0.29	0.97	0.75	0.81	0.32	0.47	0.4	0.06	-0.79	0.9		0.9	-0.53	0.68	0.95	0.86	0.33	0.94	0.4	0.96
Capital Surpluse	0.94	0.61	0.93	0.93	0.95	0.91	-0.06	0.93	0.82	0.86	0.32	0.47	0.33	0.05	-0.84	0.99	0.9		-0.59	0.76	0.82	0.71	0.48	0.9	0.58	0.89
Deferred Long Term Liab	-0.58	-0.58	-0.54	-0.59	-0.62	-0.49	-0.23	-0.55	-0.58	-0.69	-0.26	-0.4	0.22	0.04	0.66	-0.61	-0.53	-0.59		-0.32	-0.35	-0.27	-0.62	-0.52	-0.66	-0.53
Long Term Investments	0.7	0.2	0.68	0.76	0.71	0.68	-0.27	0.66	0.32	0.46	0.4	0.16	0.17	-0.18	-0.71	0.72	0.68	0.76	-0.32		0.68	0.58	0.33	0.51	0.19	0.55
Property Plant Equipment	0.91	0.69	0.92	0.88	0.88	0.94	-0.41	0.88	0.58	0.65	0.24	0.46	0.37	0.1	-0.67	0.8	0.95	0.82	-0.35	0.68		0.87	0.16	0.88	0.19	0.92
Short Long Term Debt	0.8	0.58	0.83	0.77	0.75	0.85	-0.51	0.78	0.56	0.55	0.21	0.31	0.56	0.09	-0.59	0.72	0.86	0.71	-0.27	0.58	0.87		0.0	0.78	0.08	0.79
Cash And Equivalents	0.43	0.2	0.37	0.47	0.5	0.28	0.42	0.41	0.43	0.73	0.17	0.44	-0.23	-0.05	-0.63	0.52	0.33	0.48	-0.62	0.33	0.16	0.0		0.31	0.83	0.34
Net Invested Capital	0.94	0.79	0.94	0.87	0.92	0.95	-0.09	0.94	0.87	0.85	0.21	0.54	0.42	0.17	-0.7	0.9	0.94	0.9	-0.52	0.51	0.88	0.78	0.31		0.5	0.99
Net Working Capital	0.54	0.35	0.49	0.52	0.59	0.43	0.65	0.57	0.76	0.84	0.17	0.48	0.1	0.05	-0.67	0.64	0.4	0.58	-0.66	0.19	0.19	0.08	0.83	0.5		0.45
Capital Stock	0.94	0.79	0.95	0.89	0.93	0.95	-0.17	0.93	0.8	0.84	0.22	0.55	0.35	0.16	-0.71	0.89	0.96	0.89	-0.53	0.55	0.92	0.79	0.34	0.99	0.45

Click cells to compare fundamentals

Medical EBITDA Historical Pattern

Today, most investors in Medical Properties Stock are looking for potential investment opportunities by analyzing not only static indicators but also various Medical Properties' growth ratios. Consistent increases or drops in fundamental ratios usually indicate a possible pattern that can be successfully translated into profits. However, when comparing two companies, knowing each company's ebitda growth rates may not be enough to decide which company is a better investment. That's why investors frequently use a static breakdown of Medical Properties ebitda as a starting point in their analysis.

Medical Properties EBITDA

Timeline

In a nutshell, EBITDA is calculated by adding back each of the excluded items to the post-tax profit, and can be used to compare companies with very different capital structures.

Competition

Predict Medical Properties

Ebitda Over Time

Medical Ebitda

Ebitda

486.5 Million

At this time, Medical Properties' EBITDA is fairly stable compared to the past year.

According to the company disclosure, Medical Properties Trust reported earnings before interest,tax, depreciation and amortization of 684.64 M. This is 7.79% lower than that of the Diversified REITs sector and significantly higher than that of the Real Estate industry. The ebitda for all United States stocks is 82.44% higher than that of the company.

Medical EBITDA Peer Comparison

Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Medical Properties' direct or indirect competition against its EBITDA to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Medical Properties could also be used in its relative valuation, which is a method of valuing Medical Properties by comparing valuation metrics of similar companies.

Medical Properties is currently under evaluation in ebitda category among related companies.

Medical Properties Institutional Holders

Institutional Holdings refers to the ownership stake in Medical Properties that is held by large financial organizations, pension funds or endowments. Institutions may purchase large blocks of Medical Properties' outstanding shares and can exert considerable influence upon its management. Institutional holders may also work to push the share price higher once they own the stock. Extensive social media coverage, TV shows, articles in high-profile magazines, and presentations at investor conferences help move the stock higher, increasing Medical Properties' value.

		Shares
Bank Of New York Mellon Corp	2023-12-31	6.3 M
Lasalle Investment Management Securities Llc	2023-12-31	5.4 M
Norges Bank	2023-12-31	5.2 M
Legal & General Group Plc	2023-12-31	5.2 M
Daiwa Securities Group Inc	2023-12-31	4.7 M
Northern Trust Corp	2023-12-31	4.5 M
Balyasny Asset Management Llc	2023-12-31	4.1 M
Sumitomo Mitsui Trust Holdings Inc	2024-03-31	3.9 M
Qube Research & Technologies	2023-12-31	3.6 M
Vanguard Group Inc	2023-12-31	86 M
Blackrock Inc	2023-12-31	71.9 M

Medical Fundamentals

	Return On Equity	-0.0685
	Return On Asset	0.0031
	Profit Margin	(0.63) %
	Operating Margin	1.50 %
	Current Valuation	12.53 B
	Shares Outstanding	601.6 M
	Shares Owned By Insiders	1.58 %
	Shares Owned By Institutions	74.25 %
	Number Of Shares Shorted	206.64 M
	Price To Earning	13.88 X
	Price To Book	0.31 X
	Price To Sales	2.70 X
	Revenue	871.8 M
	Gross Profit	1.54 B
	EBITDA	684.64 M
	Net Income	(558.12 M)
	Cash And Equivalents	235.67 M
	Cash Per Share	0.43 X
	Total Debt	10.17 B
	Debt To Equity	1.14 %
	Current Ratio	5.96 X
	Book Value Per Share	12.74 X
	Cash Flow From Operations	505.79 M
	Short Ratio	9.37 X
	Earnings Per Share	(0.93) X
	Price To Earnings To Growth	1.93 X
	Target Price	4.95
	Number Of Employees	121
	Beta	1.23
	Market Capitalization	2.72 B
	Total Asset	18.3 B
	Retained Earnings	(971.81 M)
	Working Capital	(567.17 M)
	Current Asset	324.63 M
	Current Liabilities	166.71 M
	Annual Yield	0.17 %
	Five Year Return	5.94 %
	Net Asset	18.3 B
	Last Dividend Paid	0.88

About Medical Properties Fundamental Analysis

The Macroaxis Fundamental Analysis modules help investors analyze Medical Properties Trust's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Medical Properties using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Medical Properties Trust based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.

Please read more on our fundamental analysis page.

Building efficient market-beating portfolios requires time, education, and a lot of computing power!

The Portfolio Architect is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.

Try AI Portfolio Architect

When determining whether Medical Properties Trust is a strong investment it is important to analyze Medical Properties' competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact Medical Properties' future performance. For an informed investment choice regarding Medical Stock, refer to the following important reports:

How To Invest In Medical

Details

Is Medical Stock a good investment?

Details

What is Medical Properties' Net Worth?

Details

Largest Diversified REITs Companies

View

Largest Equity Real Estate Investment Trusts (REITs) Companies

View

Check out Medical Properties Piotroski F Score and Medical Properties Altman Z Score analysis.

You can also try the ETFs module to find actively traded Exchange Traded Funds (ETF) from around the world.

Complementary Tools for Medical Stock analysis

When running Medical Properties' price analysis, check to measure Medical Properties' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Medical Properties is operating at the current time. Most of Medical Properties' value examination focuses on studying past and present price action to predict the probability of Medical Properties' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Medical Properties' price. Additionally, you may evaluate how the addition of Medical Properties to your portfolios can decrease your overall portfolio volatility.

	CEOs Directory Screen CEOs from public companies around the world
	Equity Forecasting Use basic forecasting models to generate price predictions and determine price momentum
	Options Analysis Analyze and evaluate options and option chains as a potential hedge for your portfolios
	AI Portfolio Architect Use AI to generate optimal portfolios and find profitable investment opportunities
	ETF Categories List of ETF categories grouped based on various criteria, such as the investment strategy or type of investments
	Price Transformation Use Price Transformation models to analyze the depth of different equity instruments across global markets
	FinTech Suite Use AI to screen and filter profitable investment opportunities
	Companies Directory Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals
	Portfolio Dashboard Portfolio dashboard that provides centralized access to all your investments
	Pattern Recognition Use different Pattern Recognition models to time the market across multiple global exchanges
	Theme Ratings Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance

Is Medical Properties' industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Medical Properties. If investors know Medical will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Medical Properties listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.

Quarterly Earnings Growth

(0.49)

Dividend Share

0.88

Earnings Share

(0.93)

Revenue Per Share

1.48

Quarterly Revenue Growth

(0.13)

The market value of Medical Properties Trust is measured differently than its book value, which is the value of Medical that is recorded on the company's balance sheet. Investors also form their own opinion of Medical Properties' value that differs from its market value or its book value, called intrinsic value, which is Medical Properties' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Medical Properties' market value can be influenced by many factors that don't directly affect Medical Properties' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.

Please note, there is a significant difference between Medical Properties' value and its price as these two are different measures arrived at by different means. Investors typically determine if Medical Properties is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Medical Properties' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2024 Macroaxis LLC

Medical Properties Trust Stock EBITDA

Medical Properties Trust Company EBITDA Analysis

EBITDA

Revenue

-

Basic Expenses

Current Medical Properties EBITDA

Medical EBITDA Driver Correlations

Medical EBITDA Historical Pattern

Medical Ebitda

Ebitda

486.5 Million

Medical EBITDA Peer Comparison

Medical Properties Institutional Holders

Medical Fundamentals

About Medical Properties Fundamental Analysis

Building efficient market-beating portfolios requires time, education, and a lot of computing power!

Complementary Tools for Medical Stock analysis

COMMON DESTINATIONS

MAIN CATEGORIES

COMPANY